Ortivus AB (publ) (STO:ORTI.B)
1.290
+0.035 (2.79%)
At close: Jan 19, 2026
Ortivus AB Revenue
Ortivus AB had revenue of 16.85M SEK in the quarter ending September 30, 2025, a decrease of -13.20%. This brings the company's revenue in the last twelve months to 75.91M, down -2.63% year-over-year. In the year 2024, Ortivus AB had annual revenue of 80.41M, down -4.36%.
Revenue (ttm)
75.91M
Revenue Growth
-2.63%
P/S Ratio
1.74
Revenue / Employee
2.23M
Employees
32
Market Cap
131.77M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 80.41M | -3.67M | -4.36% |
| Dec 31, 2023 | 84.08M | -20.43M | -19.55% |
| Dec 31, 2022 | 104.51M | 10.24M | 10.86% |
| Dec 31, 2021 | 94.27M | -13.31M | -12.37% |
| Dec 31, 2020 | 107.58M | 56.73M | 111.58% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Getinge AB | 35.85B |
| Swedish Orphan Biovitrum AB | 27.85B |
| Medicover AB | 25.67B |
| Elekta AB | 17.57B |
| Asker Healthcare Group AB | 16.41B |
| AddLife AB | 10.53B |
| Nolato AB | 9.57B |
| Vitrolife AB | 3.51B |